Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 11008907)

1.

Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.

Lee HJ, Wu K, Cox DG, Hunter D, Hankinson SE, Willett WC, Sinha R, Cho E.

Nutr Cancer. 2013;65(8):1122-31. doi: 10.1080/01635581.2013.824991. Epub 2013 Oct 7.

2.

Meat mutagens and breast cancer in postmenopausal women--a cohort analysis.

Wu K, Sinha R, Holmes MD, Giovannucci E, Willett W, Cho E.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1301-10. doi: 10.1158/1055-9965.EPI-10-0002.

3.

Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx).

Metry KJ, Neale JR, Doll MA, Howarth AL, States JC, McGregor WG, Pierce WM Jr, Hein DW.

Mutat Res. 2010 Feb 3;684(1-2):66-73. doi: 10.1016/j.mrfmmm.2009.12.001. Epub 2009 Dec 11.

4.

Well-done meat intake, heterocyclic amine exposure, and cancer risk.

Zheng W, Lee SA.

Nutr Cancer. 2009;61(4):437-46. doi: 10.1080/01635580802710741. Review.

5.

Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Ferrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, Ma X, Mayne ST, Sinha R.

Br J Cancer. 2009 Jul 7;101(1):178-84. doi: 10.1038/sj.bjc.6605118. Epub 2009 Jun 9.

6.

Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts.

Bendaly J, Metry KJ, Doll MA, Jiang G, States JC, Smith NB, Neale JR, Holloman JL, Pierce WM, Hein DW.

Xenobiotica. 2009 May;39(5):399-406. doi: 10.1080/00498250902748953.

7.

Meat intake and meat preparation in relation to risk of postmenopausal breast cancer in the NIH-AARP diet and health study.

Kabat GC, Cross AJ, Park Y, Schatzkin A, Hollenbeck AR, Rohan TE, Sinha R.

Int J Cancer. 2009 May 15;124(10):2430-5. doi: 10.1002/ijc.24203.

9.

Multiple advantageous amino acid variants in the NAT2 gene in human populations.

Luca F, Bubba G, Basile M, Brdicka R, Michalodimitrakis E, Rickards O, Vershubsky G, Quintana-Murci L, Kozlov AI, Novelletto A.

PLoS One. 2008 Sep 5;3(9):e3136. doi: 10.1371/journal.pone.0003136.

10.
11.

Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.

Zang Y, Doll MA, Zhao S, States JC, Hein DW.

Carcinogenesis. 2007 Aug;28(8):1665-71. Epub 2007 Apr 13.

12.

Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.

Kurian JR, Chin NA, Longlais BJ, Hayes KL, Trepanier LA.

Chem Res Toxicol. 2006 Oct;19(10):1366-73.

13.

Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.

Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, States JC, Hein DW.

Pharmacogenet Genomics. 2006 Jul;16(7):515-25.

16.

New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study.

Thyagarajan B, Anderson KE, Kong F, Selk FR, Lynch CF, Gross MD.

J Clin Pathol. 2005 Sep;58(9):955-61.

17.

The role of genetic polymorphisms in environmental health.

Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ.

Environ Health Perspect. 2003 Jun;111(8):1055-64. Review.

18.

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, Schaapveld M, de Vries EG.

J Med Genet. 2002 Apr;39(4):225-42. Review.

19.

Perspectives on the chemical etiology of breast cancer.

DeBruin LS, Josephy PD.

Environ Health Perspect. 2002 Feb;110 Suppl 1:119-28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk